Startup Neuraly Raises $36M to Bring Potential Disease-Modifying Treatments to Patients with Parkinson’s Disease

Startup Neuraly Raises $36M to Bring Potential Disease-Modifying Treatments to Patients with Parkinson’s Disease

Today, Neuraly announced its launch to pioneer the development of disease-modifying agents for neurodegenerative disorders. Read more >>

Share this post